(R)Evolution in Allergic Rhinitis Add-On Therapy: From Probiotics to Postbiotics and Parabiotics

被引:9
|
作者
Capponi, Martina [1 ]
Gori, Alessandra [1 ]
De Castro, Giovanna [1 ]
Ciprandi, Giorgio [2 ]
Anania, Caterina [1 ]
Brindisi, Giulia [1 ,3 ]
Tosca, Mariangela [4 ]
Cinicola, Bianca Laura [1 ,5 ]
Salvatori, Alessandra [6 ]
Loffredo, Lorenzo [7 ]
Spalice, Alberto [8 ]
Zicari, Anna Maria [1 ]
机构
[1] Sapienza Univ Rome, Dept Maternal Infantile & Urol Sci, I-00185 Rome, Italy
[2] Casa di Cura Villa Serena, Allergy Clin, I-65013 Genoa, Italy
[3] Sapienza Univ Rome, Dept Translat & Precis Med, I-00185 Rome, Italy
[4] IRCCCS Ist Giannina Gaslini, Allergy Ctr, I-65013 Genoa, Italy
[5] Sapienza Univ Rome, Dept Mol Med, I-00185 Rome, Italy
[6] Univ Campania Luigi Vanvitelli, Dept Woman & Child Gen & Specialist Surg, I-80138 Naples, Italy
[7] Sapienza Univ, Dept Internal Med & Med Specialties, I-00185 Rome, Italy
[8] Sapienza Univ Rome, Dept Pediat, Child Neurol Div, I-00185 Rome, Italy
关键词
probiotics; postbiotics; parabiotic; allergic rhinitis; immune system; microbiota; atopic march; allergic disease; allergic inflammation; GUT MICROBIOTA; AIRWAY DISEASE; CELLS; SUPPLEMENTATION; METAANALYSIS; PREVENTION; COMMENSAL; CHILDREN; BACTERIA; IMMUNITY;
D O I
10.3390/jcm11175154
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Starting from the "Hygiene Hypothesis" to the "Microflora hypothesis" we provided an overview of the symbiotic and dynamic equilibrium between microbiota and the immune system, focusing on the role of dysbiosis in atopic march, particularly on allergic rhinitis. The advent of deep sequencing technologies and metabolomics allowed us to better characterize the microbiota diversity between individuals and body sites. Each body site, with its own specific environmental niches, shapes the microbiota conditioning colonization and its metabolic functionalities. The analysis of the metabolic pathways provides a mechanistic explanation of the remote mode of communication with systems, organs, and microflora of other body sites, including the ecosystem of the upper respiratory tract. This axis may have a role in the development of respiratory allergic disease. Notably, the microbiota is significant in the development and maintenance of barrier function; influences hematopoiesis and innate immunity; and shows its critical roles in Th1, Th2, and Treg production, which are necessary to maintain immunological balance and promote tolerance, taking part in every single step of the inflammatory cascade. These are microbial biotherapy foundations, starting from probiotics up to postbiotics and parabiotics, in a still-ongoing process. When considering the various determinants that can shape microbiota, there are several factors to consider: genetic factors, environment, mode of delivery, exposure to antibiotics, and other allergy-unrelated diseases. These factors hinder the engraftment of probiotic strains but may be upgradable with postbiotic and parabiotic administration directly on molecular targets. Supplementation with postbiotics and parabiotics could represent a very exciting perspective of treatment, bypassing probiotic limitations. At present, this avenue remains theoretical and to be explored, but it will certainly be a fascinating path to follow.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Treatment of epilepsy with perampanel: conversion from add-on therapy to monotherapy
    Toledano, Rafael
    Gil-Nagel, Antonio
    REVISTA DE NEUROLOGIA, 2021, 73 : S1 - S7
  • [22] Safety analysis of a study on the effect of micronized cellulose powder as add-on to intranasal as-needed treatment of subjects with pollen allergic rhinitis
    Popov, T. A.
    Hristova, D. M.
    Valerieva, A. D.
    Kralimarkova, T.
    ALLERGY, 2018, 73 : 335 - 335
  • [23] FROM THE ANALYST'S COUCH Allergic rhinitis: market evolution
    Clark, Matthew J.
    Million, Ryan P.
    NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (04) : 271 - 272
  • [24] Zonisamide in the epilepsy treatment: a literature review from add-on therapy to monotherapy
    Villanueva, Vicente
    Serrano-Castro, Pedro J.
    REVISTA DE NEUROLOGIA, 2013, 56 (08) : 429 - 438
  • [25] Beyond statins: what to expect from add-on lipid regulating therapy?
    Laufs, Ulrich
    Weintraub, William S.
    Packard, Chris J.
    EUROPEAN HEART JOURNAL, 2013, 34 (34) : 2660 - 2665
  • [26] Response to Omalizumab as an Add-On Therapy in the Treatment of Allergic Asthma in Adult Chinese Patients-A Retrospective Study
    Li, Na
    Cao, Linfeng
    Zhang, Ming
    Fei, Chunyuan
    Deng, Jingjing
    VACCINES, 2022, 10 (12)
  • [27] Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit
    Michelle L North
    Terry J Walker
    Lisa M Steacy
    Barnaby G Hobsbawn
    Richard J Allan
    Frances Hackman
    Xiaoqun Sun
    Andrew G Day
    Anne K Ellis
    Allergy, Asthma & Clinical Immunology, 10
  • [28] Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit
    North, Michelle L.
    Walker, Terry J.
    Steacy, Lisa M.
    Hobsbawn, Barnaby G.
    Allan, Richard J.
    Hackman, Frances
    Sun, Xiaoqun
    Day, Andrew G.
    Ellis, Anne K.
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2014, 10
  • [29] Real-Life Study on the Effect of Micronized Cellulose Powder As Add-on to Intranasal As-Needed Treatment of Subjects with Pollen Allergic Rhinitis
    Popov, Todor A.
    Valerieva, Anna
    Church, Martin K.
    Staevska, Maria
    Kralimarkova, Tanya
    Petkova, Elena
    Valerieva, Elitsa
    Lazarova, Tsvetelina
    Dimitrov, Vasil
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB402 - AB402
  • [30] ECONOMIC EVALUATION OF OMALIZUMAB ADD-ON THERAPY IN PATIENTS WITH UNCONTROLLED SEVERE ALLERGIC ASTHMA FROM THE PRIVATE HEALTH CARE SYSTEM PERSPECTIVE IN BRAZIL
    Suzuki, C.
    Santoni, N. B.
    Silva, N. L.
    VALUE IN HEALTH, 2013, 16 (03) : A234 - A234